Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy

Petar M. Seferović; Hiroyuki Tsutsui; Dennis M. Mcnamara; Arsen D. Ristić; Cristina Basso; Biykem Bozkurt; Leslie T. Cooper; Gerasimos Filippatos; Tomomi Ide; Takayuki Inomata; Karin Klingel; Aleš Linhart; Alexander R. lyon; Mandeep R. Mehra; Marija Polovina; Ivan Milinković; Kazufumi Nakamura; Stefan D. Anker; Ivana Veljić; Tomohito Ohtani; Takahiro Okumura; Thomas Thum; Carsten Tschöpe; Giuseppe Rosano; Andrew J.S. Coats; Randall C. Starling

doi:10.1016/j.cardfail.2021.04.010

Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy

Petar M. Seferović, Hiroyuki Tsutsui, Dennis M. Mcnamara, Arsen D. Ristić, Cristina Basso, Biykem Bozkurt, Leslie T. Cooper, Gerasimos Filippatos, Tomomi Ide, Takayuki Inomata, Karin Klingel, Aleš Linhart, Alexander R. lyon, Mandeep R. Mehra, Marija Polovina, Ivan Milinković, Kazufumi Nakamura, Stefan D. Anker, Ivana Veljić, Tomohito OhtaniTakahiro Okumura, Thomas Thum, Carsten Tschöpe, Giuseppe Rosano, Andrew J.S. Coats, Randall C. Starling

Cardiovascular Diseases

Research output: Contribution to journal › Article › peer-review

Abstract

Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the monitoring of heart transplant rejection. In addition, EMB can have an important complementary role to the clinical assessment in establishing the diagnosis of diverse cardiac disorders, including myocarditis, cardiomyopathies, drug-related cardiotoxicity, amyloidosis, other infiltrative and storage disorders, and cardiac tumors. Improvements in EMB equipment and the development of new techniques for the analysis of EMB samples has significantly improved the diagnostic precision of EMB. The present document is the result of the Trilateral Cooperation Project between the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America, and the Japanese Heart Failure Society. It represents an expert consensus aiming to provide a comprehensive, up-to-date perspective on EMB, with a focus on the following main issues: (1) an overview of the practical approach to EMB, (2) an update on indications for EMB, (3) a revised plan for heart transplant rejection surveillance, (4) the impact of multimodality imaging on EMB, and (5) the current clinical practice in the worldwide use of EMB.

Original language	English (US)
Pages (from-to)	727-743
Number of pages	17
Journal	Journal of Cardiac Failure
Volume	27
Issue number	7
DOIs	https://doi.org/10.1016/j.cardfail.2021.04.010
State	Published - Jul 2021

Keywords

Endomyocardial biopsy
amyloidosis
cardiac tumors
cardiomyopathy
cardiotoxicity
heart failure
heart transplantation
myocarditis
sarcoidosis

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.cardfail.2021.04.010

Cite this

Seferović, P. M., Tsutsui, H., Mcnamara, D. M., Ristić, A. D., Basso, C., Bozkurt, B., Cooper, L. T., Filippatos, G., Ide, T., Inomata, T., Klingel, K., Linhart, A., lyon, A. R., Mehra, M. R., Polovina, M., Milinković, I., Nakamura, K., Anker, S. D., Veljić, I., ... Starling, R. C. (2021). Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy. Journal of Cardiac Failure, 27(7), 727-743. https://doi.org/10.1016/j.cardfail.2021.04.010

Seferović, PM, Tsutsui, H, Mcnamara, DM, Ristić, AD, Basso, C, Bozkurt, B, Cooper, LT, Filippatos, G, Ide, T, Inomata, T, Klingel, K, Linhart, A, lyon, AR, Mehra, MR, Polovina, M, Milinković, I, Nakamura, K, Anker, SD, Veljić, I, Ohtani, T, Okumura, T, Thum, T, Tschöpe, C, Rosano, G, Coats, AJS & Starling, RC 2021, 'Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy', Journal of Cardiac Failure, vol. 27, no. 7, pp. 727-743. https://doi.org/10.1016/j.cardfail.2021.04.010

@article{54cce1eeb6e647ada530d785d9aeb1dd,

title = "Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy",

abstract = "Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the monitoring of heart transplant rejection. In addition, EMB can have an important complementary role to the clinical assessment in establishing the diagnosis of diverse cardiac disorders, including myocarditis, cardiomyopathies, drug-related cardiotoxicity, amyloidosis, other infiltrative and storage disorders, and cardiac tumors. Improvements in EMB equipment and the development of new techniques for the analysis of EMB samples has significantly improved the diagnostic precision of EMB. The present document is the result of the Trilateral Cooperation Project between the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America, and the Japanese Heart Failure Society. It represents an expert consensus aiming to provide a comprehensive, up-to-date perspective on EMB, with a focus on the following main issues: (1) an overview of the practical approach to EMB, (2) an update on indications for EMB, (3) a revised plan for heart transplant rejection surveillance, (4) the impact of multimodality imaging on EMB, and (5) the current clinical practice in the worldwide use of EMB.",

keywords = "Endomyocardial biopsy, amyloidosis, cardiac tumors, cardiomyopathy, cardiotoxicity, heart failure, heart transplantation, myocarditis, sarcoidosis",

author = "Seferovi{\'c}, {Petar M.} and Hiroyuki Tsutsui and Mcnamara, {Dennis M.} and Risti{\'c}, {Arsen D.} and Cristina Basso and Biykem Bozkurt and Cooper, {Leslie T.} and Gerasimos Filippatos and Tomomi Ide and Takayuki Inomata and Karin Klingel and Ale{\v s} Linhart and lyon, {Alexander R.} and Mehra, {Mandeep R.} and Marija Polovina and Ivan Milinkovi{\'c} and Kazufumi Nakamura and Anker, {Stefan D.} and Ivana Velji{\'c} and Tomohito Ohtani and Takahiro Okumura and Thomas Thum and Carsten Tsch{\"o}pe and Giuseppe Rosano and Coats, {Andrew J.S.} and Starling, {Randall C.}",

note = "Publisher Copyright: {\textcopyright} 2021",

year = "2021",

month = jul,

doi = "10.1016/j.cardfail.2021.04.010",

language = "English (US)",

volume = "27",

pages = "727--743",

journal = "Journal of Cardiac Failure",

issn = "1071-9164",

publisher = "Churchill Livingstone",

number = "7",

}

TY - JOUR

T1 - Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy

AU - Seferović, Petar M.

AU - Tsutsui, Hiroyuki

AU - Mcnamara, Dennis M.

AU - Ristić, Arsen D.

AU - Basso, Cristina

AU - Bozkurt, Biykem

AU - Cooper, Leslie T.

AU - Filippatos, Gerasimos

AU - Ide, Tomomi

AU - Inomata, Takayuki

AU - Klingel, Karin

AU - Linhart, Aleš

AU - lyon, Alexander R.

AU - Mehra, Mandeep R.

AU - Polovina, Marija

AU - Milinković, Ivan

AU - Nakamura, Kazufumi

AU - Anker, Stefan D.

AU - Veljić, Ivana

AU - Ohtani, Tomohito

AU - Okumura, Takahiro

AU - Thum, Thomas

AU - Tschöpe, Carsten

AU - Rosano, Giuseppe

AU - Coats, Andrew J.S.

AU - Starling, Randall C.

PY - 2021/7

Y1 - 2021/7

N2 - Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the monitoring of heart transplant rejection. In addition, EMB can have an important complementary role to the clinical assessment in establishing the diagnosis of diverse cardiac disorders, including myocarditis, cardiomyopathies, drug-related cardiotoxicity, amyloidosis, other infiltrative and storage disorders, and cardiac tumors. Improvements in EMB equipment and the development of new techniques for the analysis of EMB samples has significantly improved the diagnostic precision of EMB. The present document is the result of the Trilateral Cooperation Project between the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America, and the Japanese Heart Failure Society. It represents an expert consensus aiming to provide a comprehensive, up-to-date perspective on EMB, with a focus on the following main issues: (1) an overview of the practical approach to EMB, (2) an update on indications for EMB, (3) a revised plan for heart transplant rejection surveillance, (4) the impact of multimodality imaging on EMB, and (5) the current clinical practice in the worldwide use of EMB.

AB - Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the monitoring of heart transplant rejection. In addition, EMB can have an important complementary role to the clinical assessment in establishing the diagnosis of diverse cardiac disorders, including myocarditis, cardiomyopathies, drug-related cardiotoxicity, amyloidosis, other infiltrative and storage disorders, and cardiac tumors. Improvements in EMB equipment and the development of new techniques for the analysis of EMB samples has significantly improved the diagnostic precision of EMB. The present document is the result of the Trilateral Cooperation Project between the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America, and the Japanese Heart Failure Society. It represents an expert consensus aiming to provide a comprehensive, up-to-date perspective on EMB, with a focus on the following main issues: (1) an overview of the practical approach to EMB, (2) an update on indications for EMB, (3) a revised plan for heart transplant rejection surveillance, (4) the impact of multimodality imaging on EMB, and (5) the current clinical practice in the worldwide use of EMB.

KW - Endomyocardial biopsy

KW - amyloidosis

KW - cardiac tumors

KW - cardiomyopathy

KW - cardiotoxicity

KW - heart failure

KW - heart transplantation

KW - myocarditis

KW - sarcoidosis

UR - http://www.scopus.com/inward/record.url?scp=85109423242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85109423242&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2021.04.010

DO - 10.1016/j.cardfail.2021.04.010

M3 - Article

C2 - 34022400

AN - SCOPUS:85109423242

SN - 1071-9164

VL - 27

SP - 727

EP - 743

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

IS - 7

ER -

Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this